抗体医薬品の世界市場2019

【英語タイトル】Global Antibody Drugs Sales Market Report 2019

QYResearchが出版した調査資料(WR-048403)・商品コード:WR-048403
・発行会社(調査会社):QYResearch
・発行日:2019年6月
・ページ数:約110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise(法人閲覧用)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、抗体医薬品の世界市場について調査・分析し、抗体医薬品の市場規模、市場動向、種類別分析、用途別分析、主要地域別市場規模予測、関連企業情報など、以下の構成でお届け致します。
【レポートの概要】

This report studies the global Antibody Drugs market status and forecast, categorizes the global Antibody Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in the United States, Europe, China, Japan, Southeast Asia and India.

By product type
 Monoclonal Antibodies
 Antibody-Drug Conjugates
 Polyclonal Antibodies

By Application
 Central Nervous System (CNS) Disorders
 Cancers
 Autoimmune Disorders
 Cardiovascular Diseases

By Company
 Novartis
 Amgen
 Bristol-Myers Squibb
 Roche
 Johnson & Johnson
 AbbVie
 Eli Lilly
 Pfizer
 Bayer
 GlaxoSmithKline
 Sanofi

【レポートの目次】

1 ANTIBODY DRUGS MARKET OVERVIEW
1.1 ANTIBODY DRUGS PRODUCT SCOPE
1.2 ANTIBODY DRUGS SEGMENT BY TYPE
1.2.1 Global Antibody Drugs Sales Comparison by Types (2014-2025)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 ANTIBODY DRUGS SEGMENT BY APPLICATION
1.3.1 Global Antibody Drugs Sales Comparison by Application (2014-2025)
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 ANTIBODY DRUGS SEGMENT BY REGION
1.4.1 Global Antibody Drugs Revenue Comparison by Region (2014-2025)
1.4.2 United States Antibody Drugs Status and Prospect (2014-2025)
1.4.3 Europe Antibody Drugs Status and Prospect (2014-2025)
1.4.4 China Antibody Drugs Status and Prospect (2014-2025)
1.4.5 Japan Antibody Drugs Status and Prospect (2014-2025)
1.4.6 Southeast Asia Antibody Drugs Status and Prospect (2014-2025)
1.4.7 India Antibody Drugs Status and Prospect (2014-2025)
1.5 GLOBAL ANTIBODY DRUGS SALES AND REVENUE (2014-2025)
1.5.1 Global Antibody Drugs Sales Growth Rate (2014-2025)
1.5.2 Global Antibody Drugs Revenue Growth Rate (2014-2025)
2 ANTIBODY DRUGS BY COMPANY, REGION, TYPE AND APPLICATION
2.1 GLOBAL ANTIBODY DRUGS MARKET COMPETITION BY COMPANIES
2.1.1 Global Antibody Drugs Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Antibody Drugs Revenue Market Share by Company (2014-2019)
2.2 GLOBAL ANTIBODY DRUGS SALES AND REVENUE BY REGION
2.2.1 Global Antibody Drugs Sales Market Share by Region (2014-2019)
2.2.2 Global Antibody Drugs Revenue Market Share by Region (2014-2019)
2.3 GLOBAL ANTIBODY DRUGS SALES AND REVENUE BY TYPE
2.3.1 Global Antibody Drugs Sales Market Share by Type (2014-2019)
2.3.2 Global Antibody Drugs Revenue Market Share by Type (2014-2019)
2.4 GLOBAL ANTIBODY DRUGS SALES BY APPLICATION
3 UNITED STATES ANTIBODY DRUGS SALES, REVENUE AND PRICE
3.1 UNITED STATES ANTIBODY DRUGS SALES AND REVENUE (2014-2019)
3.1.1 United States Antibody Drugs Sales Growth Rate (2014-2019)
3.1.2 United States Antibody Drugs Revenue Growth Rate (2014-2019)
3.1.3 United States Antibody Drugs Price Trend (2014-2019)
3.2 UNITED STATES ANTIBODY DRUGS SALES MARKET SHARE BY COMPANY
3.3 UNITED STATES ANTIBODY DRUGS SALES MARKET SHARE BY TYPE
3.4 UNITED STATES ANTIBODY DRUGS SALES MARKET SHARE BY APPLICATION
4 EUROPE ANTIBODY DRUGS SALES, REVENUE AND PRICE
4.1 EUROPE ANTIBODY DRUGS SALES AND VALUE (2014-2019)
4.1.1 Europe Antibody Drugs Sales Growth Rate (2014-2019)
4.1.2 Europe Antibody Drugs Revenue Growth Rate (2014-2019)
4.1.3 Europe Antibody Drugs Price Trend (2014-2019)
4.2 EUROPE ANTIBODY DRUGS SALES MARKET SHARE BY COMPANY
4.3 EUROPE ANTIBODY DRUGS SALES MARKET SHARE BY TYPE
4.4 EUROPE ANTIBODY DRUGS SALES MARKET SHARE BY APPLICATION
5 CHINA ANTIBODY DRUGS SALES, REVENUE AND PRICE
5.1 CHINA ANTIBODY DRUGS SALES AND REVENUE (2014-2019)
5.1.1 China Antibody Drugs Sales Growth Rate (2014-2019)
5.1.2 China Antibody Drugs Revenue Growth Rate (2014-2019)
5.1.3 China Antibody Drugs Price Trend (2014-2019)
5.2 CHINA ANTIBODY DRUGS SALES MARKET SHARE BY COMPANY
5.3 CHINA ANTIBODY DRUGS SALES MARKET SHARE BY TYPE
5.4 CHINA ANTIBODY DRUGS SALES MARKET SHARE BY APPLICATION
6 JAPAN ANTIBODY DRUGS SALES, REVENUE AND PRICE
6.1 JAPAN ANTIBODY DRUGS SALES AND VALUE (2014-2019)
6.1.1 Japan Antibody Drugs Sales Growth Rate (2014-2019)
6.1.2 Japan Antibody Drugs Revenue Growth Rate (2014-2019)
6.1.3 Japan Antibody Drugs Price Trend (2014-2019)
6.2 JAPAN ANTIBODY DRUGS SALES MARKET SHARE BY COMPANY
6.3 JAPAN ANTIBODY DRUGS SALES MARKET SHARE BY TYPE
6.4 JAPAN ANTIBODY DRUGS SALES MARKET SHARE BY APPLICATION
7 SOUTHEAST ASIA ANTIBODY DRUGS SALES, REVENUE AND PRICE
7.1 SOUTHEAST ASIA ANTIBODY DRUGS SALES AND VALUE (2014-2019)
7.1.1 Southeast Asia Antibody Drugs Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Antibody Drugs Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Antibody Drugs Price Trend (2014-2019)
7.2 SOUTHEAST ASIA ANTIBODY DRUGS SALES MARKET SHARE BY COMPANY
7.3 SOUTHEAST ASIA ANTIBODY DRUGS SALES MARKET SHARE BY TYPE
7.4 SOUTHEAST ASIA ANTIBODY DRUGS SALES MARKET SHARE BY APPLICATION
8 INDIA ANTIBODY DRUGS SALES, REVENUE AND PRICE
8.1 INDIA ANTIBODY DRUGS SALES AND VALUE (2014-2019)
8.1.1 India Antibody Drugs Sales Growth Rate (2014-2019)
8.1.2 India Antibody Drugs Revenue Growth Rate (2014-2019)
8.1.3 India Antibody Drugs Price Trend (2014-2019)
8.2 INDIA ANTIBODY DRUGS SALES MARKET SHARE BY COMPANY
8.3 INDIA ANTIBODY DRUGS SALES MARKET SHARE BY TYPE
8.4 INDIA ANTIBODY DRUGS SALES MARKET SHARE BY APPLICATION
9 COMPANY PROFILES AND KEY FIGURES IN ANTIBODY DRUGS BUSINESS
9.1 NOVARTIS
9.1.1 Novartis Antibody Drugs Production Sites and Area Served
9.1.2 Novartis Antibody Drugs Specification and Application
9.1.3 Novartis Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Novartis Main Business and Markets Served
9.2 AMGEN
9.2.1 Amgen Antibody Drugs Production Sites and Area Served
9.2.2 Amgen Antibody Drugs Specification and Application
9.2.3 Amgen Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Amgen Main Business and Markets Served
9.3 BRISTOL-MYERS SQUIBB
9.3.1 Bristol-Myers Squibb Antibody Drugs Production Sites and Area Served
9.3.2 Bristol-Myers Squibb Antibody Drugs Specification and Application
9.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Bristol-Myers Squibb Main Business and Markets Served
9.4 ROCHE
9.4.1 Roche Antibody Drugs Production Sites and Area Served
9.4.2 Roche Antibody Drugs Specification and Application
9.4.3 Roche Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Roche Main Business and Markets Served
9.5 JOHNSON & JOHNSON
9.5.1 Johnson & Johnson Antibody Drugs Production Sites and Area Served
9.5.2 Johnson & Johnson Antibody Drugs Specification and Application
9.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Johnson & Johnson Main Business and Markets Served
9.6 ABBVIE
9.6.1 AbbVie Antibody Drugs Production Sites and Area Served
9.6.2 AbbVie Antibody Drugs Specification and Application
9.6.3 AbbVie Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 AbbVie Main Business and Markets Served
9.7 ELI LILLY
9.7.1 Eli Lilly Antibody Drugs Production Sites and Area Served
9.7.2 Eli Lilly Antibody Drugs Specification and Application
9.7.3 Eli Lilly Antibody Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Eli Lilly Main Business and Markets Served
9.8 PFIZER
9.9 BAYER
9.10 GLAXOSMITHKLINE
9.11 SANOFI
10 ANTIBODY DRUGS MANUFACTURING COST ANALYSIS
10.1 ANTIBODY DRUGS KEY RAW MATERIALS ANALYSIS
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 PROPORTION OF MANUFACTURING COST STRUCTURE
10.3 MANUFACTURING PROCESS ANALYSIS OF ANTIBODY DRUGS
10.4 ANTIBODY DRUGS INDUSTRIAL CHAIN ANALYSIS
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 MARKETING CHANNEL
11.2 ANTIBODY DRUGS DISTRIBUTORS LIST
11.3 ANTIBODY DRUGS CUSTOMERS
12 MARKET DYNAMICS
12.1 MARKET TRENDS
12.2 OPPORTUNITIES AND DRIVERS
12.3 CHALLENGES
12.4 PORTER’S FIVE FORCES ANALYSIS
13 ANTIBODY DRUGS MARKET FORECAST
13.1 GLOBAL ANTIBODY DRUGS SALES, REVENUE AND PRICE FORECAST
13.1.1 Global Antibody Drugs Sales Growth Forecast (2019-2025)
13.1.2 Global Antibody Drugs Revenue Growth Forecast (2019-2025)
13.1.3 Global Antibody Drugs Price Trend Forecast (2019-2025)
13.2 GLOBAL ANTIBODY DRUGS FORECAST BY REGION
13.2.1 Global Antibody Drugs Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Antibody Drugs Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Antibody Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Antibody Drugs Sales, Revenue (Million USD) Growth Rate Forecast (2019-2025)
13.2.5 China Antibody Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Antibody Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Antibody Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Antibody Drugs Sales, Revenue Growth Forecast (2019-2025)
13.3 GLOBAL ANTIBODY DRUGS FORECAST BY TYPE
13.3.1 Global Antibody Drugs Sales Forecast by Type (2019-2025)
13.3.2 Global Antibody Drugs Revenue Forecast by Type (2019-2025)
13.3.3 Global Antibody Drugs Price Forecast by Type (2019-2025)
13.4 GLOBAL ANTIBODY DRUGS FORECAST BY APPLICATION
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 RESEARCH METHODOLOGY
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 AUTHOR DETAILS
15.3 DISCLAIMER



★調査レポート[抗体医薬品の世界市場2019] (コード:WR-048403)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗体医薬品の世界市場2019]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆